Inhibitory effect of a traditional Chinese medicine, Juzen-taiho-to, on progressive growth of weakly malignant clone cells derived from murine fibrosarcoma

Japanese Journal of Cancer Research

Volumn 87, Issue 10, 1996, Pages 1039-1044

  Ohnishi, Yasuharu ^a   Fujii, Hideki ^a   Kimura, Fuminari ^a   Mishima, Takaaki ^a   Murata, Jun ^a   Tazawa, Kenji ^a   Fujimaki, Masao ^a   Okada, Futoshi ^b   Hosokawa, Masuo ^b   Saiki, Ikuo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Juzen taiho to; Progressive growth; Tumor progression

Indexed keywords

BISMUTH NITRATE; GELATIN SPONGE; KAMPO;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER SURVIVAL; CHINESE MEDICINE; CONTROLLED STUDY; DRUG DEVELOPMENT; FEMALE; FIBROSARCOMA; HERBAL MEDICINE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 10544235437     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1996.tb03107.x     Document Type: Article

References (27)

1. Foulds, L. Tumor progression. Cancer Res., 17, 355-356 (1957).
2. Nowell, P.C. Mechanisms of tumor progression. Cancer Res., 46, 2203-2207 (1986).
3. Ishikawa, M., Okada, F., Hamada, J., Hosokawa, M. and Kobayashi, H. Changes in the tumorigenic and metastatic properties of tumor cells treated with quercetin or 5-azacytidine. Int. J. Cancer, 39, 338-342 (1987).
4. 2. Cancer Immunol. Immunother., 31, 358-364 (1990).
5. Okada, F., Hosokawa, M., Hamada, J., Hasegawa, J., Kato, M., Mizutani, M., Ren, J., Takeichi, N. and Kobayashi, H. Malignant progression of a mouse fibrosarcoma by host cells reactive to a foreign body (gelatin sponge). Br. J. Cancer, 66, 635-639 (1992).
6. Greene, R. F., Chatterji, D. C., Hiranaka, P. K. and Gallelli, J. F. Stability of cisplatin in aqueous solution. Am. J. Hosp. Pharm., 36, 38-43 (1979).
7. Maruyama, H., Kawamura, H., Takemoto, N., Komatsu, Y., Aburada, M. and Hosoya, E. Effect of Juzentaihoto on phagocytes. Jpn. J. Inflamm., 8, 461-465 (1988) (in Japanese).
8. Haranaka, K., Satomi, N., Sakurai, A., Haranaka, R., Okada, N. and Kobayashi, M. Antitumor activities and tumor necrosis factor producibility of traditional Chinese medicines and crude drugs. Cancer Immunol. Immunother., 20, 1-5 (1985).
9. Kubota, A., Okamura, S., Shimoda, K., Harada, N., Omori, F. and Niho, Y. A traditional Chinese herbal medicine, Juzen-taiho-to, augments the production of granulocyte/macrophage colony-stimulating factor from human peripheral blood mononuclear cells in vitro. Int. J. Immunother., 8, 191-195 (1992).
10. Hamada, M., Fujii, Y., Yamamoto, H., Miyazawa, Y., Shui, S. M., Tung, Y. C. and Yamaguchi, N. Effect of a kampo medicine, zyuzentaihoto, on the immune reactivity of tumor-bearing mice. J. Ethnopharma., 24, 311-320 (1988).
11. Kiyohara, H., Takemoto, N., Komatsu, Y., Kawamura, H., Hosoya, E. and Yamada, H. Characterization of mitogenic oeptic polysaccharides from kampo (Japanese herbal) medicine "Juzen-Taiho-To." Planta Med., 57, 254-259 (1991).
12. Haranaka, R., Hasegawa, R., Nakagawa, S., Sakurai, A., Satomi, N. and Haranaka, K. Antitumor activity of combination therapy with traditional Chinese medicine and OK432 or MMC. J. Biol. Response Mod., 7, 77-90 (1988).
13. Sugiyama, K., Ueda, H., Ichio, Y. and Yokota, M. Improvement of cisplatin toxicity and lethality by Juzen-taiho-to in mice. Biol. Pharm. Bull., 18, 53-58 (1995).
14. Sugiyama, K., Ueda, H. and Ichio, Y. Protective effect of Juzen-taiho-to against Carboplatin-induced toxic side effects in mice. Biol. Pharm. Bull., 18, 544-548 (1995).
15. Ohnishi, Y., Yasumizu, R., Fan, H., Liu, L., Takao-Liu, F., Komatsu, Y., Hosoya, E., Good, R. A. and Ikehara, S. Effects of Juzen-taiho-toh (TJ-48), a traditional oriental medicine, on hematopoietic recovery from radiation injury in mice. Exp. Hematol., 18, 18-22 (1990).
16. Kawamura, H., Maruyama, H., Takemoto, N., Komatsu, Y., Aburada, M., Ikehara, S. and Hosoya, E. Accelerating effect of Japanese kampo medicine on recovery of murine haematopoietic stem cells after administration of mitomycin C. Int. J. Immunother., 5, 35-42 (1989).
17. Ishikawa, M., Hosokawa, M., Oh-hara, N., Niho, Y. and Kobayashi, H. Marked granulocytosis in C57BL/6 mice bearing a transplanted BMT-11 fibrosarcoma. J. Natl. Cancer Inst., 78, 567-571 (1987).
18. Satoh, M., Miura, N., Naganuma, A., Matsuzaki, N., Kawamura, E. and Imura, N. Prevention of adverse effects of gamma-ray irradiation after metallothionein induction by bismuth subnitrate in mice. Eur. J. Cancer Clin. Oncol., 25, 1727-1731(1989).
19. 2-mediated suppression of cellular immunity in colon cancer patients. Surgery, 95, 71-77 (1984).
20. Pelus, L. M. and Bockman, R. S. Increased prostaglandin synthesis by macrophages from tumor-bearing mice. J. Immunol., 123, 2118-2125 (1979).
21. 2 produced by macrophage. Cancer Res., 46, 160-164 (1986).
22. 2 production by mouse fibrosarcoma cells after co-culture with various anti-tumor effector cells. Br. J. Cancer, 70, 233-238 (1994).
23. Okada, F., Kobayashi, H., Hamada, J.,Takeichi, N. and Hosokawa, M. Active radicals produced by host reactive cells in the malignant progression of murine tumor cells. Proc. Am. Assoc. Cancer Res., 34, 1060 (1993).
24. Okada, F. and Hosokawa, M. Tumor progression accelerated by active oxygen species and its chemoprevention. Int. Conf. Food Factors, p. 71 (1995).
25. Takahashi, H. and Nakazawa, S. Antitumor effect of Juzen-taiho-to, a Kampo medicine, for transplanted malignant glioma. Int. J. Immunother., 11, 65 (1995).
26. Sato, K., Mochizuki, M., Saiki, I., Yoo, Y. C., Samukawa, K. and Azuma, I. Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2. Biol. Pharm. Bull., 17, 635-639 (1994).
27. Mochizuki, M., Yoo, Y. C., Matsuzawa, K., Sato, K., Saiki, I., Tono-oka, S., Samukawa, K. and Azuma, I. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of Red ginseng. Biol. Pharm. Bull., 18, 1197-1202 (1995).